Abstract
The medical management of secondary brain injury is entering a new era in which the fruits of labor in the laboratory are paying off in the form of legitimate agents for use in human trials. As more about pathophysiology of traumatic-ischemic brain injury becomes known, more effective means for pharmacologic intervention and neuronal salvage will emerge, and optimism is high that we are approaching an era that will witness improvements in functional survival that have been heretofore unwitnessed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
